These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2913726)

  • 1. [Changes in fatty acid metabolism in dilated cardiomyopathy and hypertrophic cardiomyopathy in childhood].
    Thies WR; Vyska K; Matthies W; Notohamiprodjo G; Knapp W; Meyer H
    Wien Klin Wochenschr; 1989 Jan; 101(1):8-11. PubMed ID: 2913726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-nuclide study of the myocardium using 201Tl and 123I-labeled fatty acids in non-ischemic myocardial diseases.
    Knapp WH; Vyska K; Machulla HJ; Notohamiprodjo G; Schmidt U; Knust EJ; Gleichmann U
    Nuklearmedizin; 1988 Jun; 27(3):72-8. PubMed ID: 3405780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [123I]-phenylpentadecanoic acid uptake in patients with dilated cardiomyopathy.
    Miche E; Radzewitz A; Notohamiprodjo G; Baller D; Kloppe A; Eckert S; Gleichmann U
    Eur J Heart Fail; 2002 Aug; 4(4):431-8. PubMed ID: 12167380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum carnitine concentrations in patients with idiopathic hypertrophic cardiomyopathy: relationship with impaired myocardial fatty acid metabolism.
    Nakamura T; Sugihara H; Kinoshita N; Ito K; Adachi Y; Hirasaki S; Matsuo A; Azuma A; Kodo N; Nakagawa M
    Clin Sci (Lond); 1999 Oct; 97(4):493-501. PubMed ID: 10491350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.
    Tuunanen H; Kuusisto J; Toikka J; Jääskeläinen P; Marjamäki P; Peuhkurinen K; Viljanen T; Sipola P; Stolen KQ; Hannukainen J; Nuutila P; Laakso M; Knuuti J
    J Nucl Cardiol; 2007; 14(3):354-65. PubMed ID: 17556170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenylpentadecanoic acid and tomographic imaging.
    Ugolini V; Hansen CL; Kulkarni PV; Jansen DE; Akers MS; Corbett JR
    Am J Cardiol; 1988 Nov; 62(13):923-8. PubMed ID: 3263035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
    Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
    J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do repolarization abnormalities in hypertrophic cardiomyopathy represent impaired fatty acid utilization? An observation with QRST isointegral maps.
    Kawakami Y; Shimada S; Sakai Y; Suwa M; Nagao H; Hirota Y; Kawamura K; Adachi I; Narabayashi I
    J Electrocardiol; 1997 Jan; 30(1):21-9. PubMed ID: 9005883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Scintigraphic imaging of adrenergic structures of the heart with 123(I)-metaiodobenzylguanidine in cardiomyopathy].
    Grötz J; Franitza R; Mödder G; Hossmann V
    Z Kardiol; 1988 May; 77(5):278-81. PubMed ID: 3407271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
    Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W
    Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fatty acid metabolism in patients with idiopathic dilated cardiomyopathy: characteristics and prognostic implications].
    Narita M; Kurihara T
    J Cardiol; 1995 May; 25(5):223-31. PubMed ID: 7776191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radionuclide assessment of myocardial failure: importance of metabolic mapping].
    Nishimura T; Nagata S; Uehara T; Shimonagata T; Miyatake K
    Jpn Circ J; 1992; 56 Suppl 5():1291-3. PubMed ID: 1291711
    [No Abstract]   [Full Text] [Related]  

  • 15. [123I-metaiodobenzylguanidine myocardial images for assessment of sympathetic nervous system in the heart].
    Tanaka T; Aizawa T; Kato K
    Kokyu To Junkan; 1991 Aug; 39(8):755-66. PubMed ID: 1925097
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of myocardial damage in dilated-phase hypertrophic cardiomyopathy by using indium-111-antimyosin Fab myocardial scintigraphy.
    Nishimura T; Nagata S; Uehara T; Hayashida K; Mitani I; Kumita S
    J Nucl Med; 1991 Jul; 32(7):1333-7. PubMed ID: 2066786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy.
    Neglia D; De Caterina A; Marraccini P; Natali A; Ciardetti M; Vecoli C; Gastaldelli A; Ciociaro D; Pellegrini P; Testa R; Menichetti L; L'Abbate A; Stanley WC; Recchia FA
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3270-8. PubMed ID: 17921325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of hypertrophic cardiomyopathy with progressive cavity dilatation--a review of serial 201Tl myocardial imaging].
    Hirasaki S; Nakamuru T; Matsubara K; Matsumuro A; Azuma A; Sugihara H; Kohno Y; Katsume H; Nakagawa M
    Kokyu To Junkan; 1991 Aug; 39(8):837-40. PubMed ID: 1925107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
    Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
    Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Washout rate in hypertrophic cardiomyopathy assessed by exercise myocardial scintigraphy].
    Genda A; Igarashi Y; Mizuno S; Sugihara N; Kita Y; Suematsu T; Shimizu M; Takeda R; Bunko H; Hisada K
    J Cardiogr; 1986 Dec; 16(4):893-905. PubMed ID: 3429906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.